litlas
Log inCreate account

The NCI60 human tumour cell line anticancer drug screen

Authors: Robert H. Shoemaker - Nature reviews. Cancer 2006 cited by 2,672

Display and Analysis ofPatterns of Differentia…Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE AlgorithmFeasibility of aHigh-Flux Anticancer…Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesMorphological andimmunocytochemical…Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen.Neural Computing inCancer Drug Development…Neural Computing in Cancer Drug Development: Predicting Mechanism of ActionMultidrug-resistantphenotype of…Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening.Some practicalconsiderations and…Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screenGeneration of a drugresistance profile by…Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.An Information-IntensiveApproach to the…An Information-Intensive Approach to the Molecular Pharmacology of CancerA gene expressiondatabase for the…A gene expression database for the molecular pharmacology of cancerSystematic variation ingene expression pattern…Systematic variation in gene expression patterns in human cancer cell linesThe NCI Human Tumor CellLine (60-Cell) ScreenThe NCI Human Tumor Cell Line (60-Cell) ScreenPredicting drugsensitivity and…Predicting drug sensitivity and resistanceAnticancer medicines indevelopment: assessment…Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening datamRNA and microRNAExpression Profiles of…mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug ActivitiesThe Exomes of the NCI-60Panel: A Genomic…The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems PharmacologyThe Clinical Relevanceof Cancer Cell LinesThe Clinical Relevance of Cancer Cell LinesAn Interactive Resourceto Identify Cancer…An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small MoleculesAccurate Models for P-gpDrug Recognition Induce…Accurate Models for P-gp Drug Recognition Induced from a Cancer Cell Line Cytotoxicity ScreenChoosing the right cellline for renal cell…Choosing the right cell line for renal cell cancer researchAn unbiased metric ofantiproliferative drug…An unbiased metric of antiproliferative drug effect in vitroMachine learning andfeature selection for…Machine learning and feature selection for drug response prediction in precision oncology applicationsThe LL-100 panel: 100cell lines for blood…The LL-100 panel: 100 cell lines for blood cancer studiesAn Improved AnticancerDrug-Response Predictio…An Improved Anticancer Drug-Response Prediction Based on an Ensemble Method Integrating Matrix Completion and Ridge RegressionMachine learning in theprediction of cancer…Machine learning in the prediction of cancer therapyThe NCI60 human tumourcell line anticancer…The NCI60 human tumour cell line anticancer drug screenEarlier referencesFocus paperCiting papersOlderNewer

Click a node to pin it, click the empty canvas to go back to this paper, or hover to preview. Open a node’s page from its title.